Drugs / GA2
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05468606 | Feb 2023 → Dec 2024 | Plasmodium falciparum malaria | Leiden University Medical Center | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GA2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05468606 ↗ |
| Known as | Pf∆mei2 | “Single immunization with genetically attenuated Pf∆mei2 (GA2) parasites by mosquito bite in controlled human malaria infection: a placebo-controlled randomized trial.” PMID 39753962 ↗ Jan 2025 |
| Route | Other | “GA2 sporozoites administered by 50 mosquito bites” NCT05468606 ↗ |